First Time Loading...
L

Labgenomics Co Ltd
KOSDAQ:084650

Watchlist Manager
Labgenomics Co Ltd
KOSDAQ:084650
Watchlist
Price: 2 750 KRW -0.18% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Labgenomics Co Ltd

Wall Street analysts forecast Labgenomics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Labgenomics Co Ltd is 5 100 KRW with a low forecast of 5 050 KRW and a high forecast of 5 250 KRW.

Lowest Forecast
Wall Street Target
5 050 KRW
84% Upside
Average Forecast
Wall Street Target
5 100 KRW
85% Upside
Highest Forecast
Wall Street Target
5 250 KRW
91% Upside
Lowest
Price Target
5 050 KRW
84% Upside
Average
Price Target
5 100 KRW
85% Upside
Highest
Price Target
5 250 KRW
91% Upside
Labgenomics Co Ltd Competitors:
Price Targets
G
144510
GC Cell Corp
93% Upside
STOK
Stoke Therapeutics Inc
107% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
14% Upside
FHTX
Foghorn Therapeutics Inc.
130% Upside
G
144510
GC Cell Corp
93% Upside
STOK
Stoke Therapeutics Inc
107% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
14% Upside
FHTX
Foghorn Therapeutics Inc.
130% Upside
688520
Sinocelltech Group Ltd
41% Upside
4597
Solasia Pharma KK
221% Upside
ABBV
Abbvie Inc
16% Upside
SNSE
Sensei Biotherapeutics Inc
188% Upside

Revenue
Forecast

Revenue Estimate
Labgenomics Co Ltd

For the last 8 years the compound annual growth rate for Labgenomics Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 42%.

15%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Labgenomics Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Labgenomics Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Labgenomics Co Ltd's stock price target?
Price Target
5 100 KRW

According to Wall Street analysts, the average 1-year price target for Labgenomics Co Ltd is 5 100 KRW with a low forecast of 5 050 KRW and a high forecast of 5 250 KRW.

What is Labgenomics Co Ltd's Revenue forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for Labgenomics Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 42%.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.